Director at Baxter (NYSE: BAX) receives 12,836 fully vested share award, now holds 37,076

Rhea-AI Filing Summary

Wilkes David S. reported acquisition or exercise transactions in this Form 4 filing.

Baxter International Inc. director David S. Wilkes received a grant of 12,836 fully vested shares of common stock. The grant was recorded at a price of $0.00 per share, reflecting a share award rather than a market purchase. Following this award and automatic reinvestment of dividends, Wilkes now directly holds a total of 37,076 Baxter common shares.

Insider Trade Summary

Net Buyer: 12,836 shares

Net Buy 1 txn

Insider Wilkes David S.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $1 par value	12,836	$0.00	$0.00

Holdings After Transaction: Common Stock, $1 par value — 37,076 shares (Direct)

Footnotes (2)

1. F1. The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.
2. F2. Total includes the automatic reinvestment of dividends.

Key Figures

Shares granted: 12,836 shares Post-transaction holdings: 37,076 shares Grant price per share: $0.00 per share

3 metrics

Shares granted 12,836 shares Fully vested common stock grant on May 5, 2026

Post-transaction holdings 37,076 shares Total common shares directly held after grant

Grant price per share $0.00 per share Award recorded as a no-cost stock grant

Key Terms

fully vested shares, automatic reinvestment of dividends, grant of fully vested shares of common stock

3 terms

fully vested shares financial

"received a grant of fully vested shares of common stock of Baxter International Inc."

automatic reinvestment of dividends financial

"Total includes the automatic reinvestment of dividends."

grant of fully vested shares of common stock financial

"received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions"

FAQ

What insider transaction did Baxter (BAX) director David S. Wilkes report?

David S. Wilkes reported receiving a grant of 12,836 fully vested Baxter common shares. The award was recorded at $0.00 per share, indicating a compensation-related stock grant rather than an open-market purchase, and increased his direct holdings to 37,076 shares.

How many Baxter (BAX) shares does David S. Wilkes hold after this Form 4?

After the reported grant, David S. Wilkes directly holds 37,076 Baxter common shares. This total includes the newly granted 12,836 fully vested shares as well as shares accumulated through the automatic reinvestment of dividends referenced in the filing footnotes.

Was the Baxter (BAX) share grant to David S. Wilkes an open-market purchase?

No, the 12,836 shares were granted at $0.00 per share, indicating a stock award rather than an open-market purchase. The filing describes the transaction as a grant of fully vested common stock, subject to the applicable grant terms and conditions.

What does “fully vested shares” mean in the Baxter (BAX) Form 4 for David S. Wilkes?

“Fully vested shares” means the 12,836 Baxter common shares granted to David S. Wilkes are not subject to future vesting conditions. He has full ownership under the applicable grant terms, rather than needing to meet additional service or performance requirements to secure the shares.

How do dividends affect David S. Wilkes’ Baxter (BAX) share holdings?

The filing notes that his total holdings include the automatic reinvestment of dividends. This means dividends paid on Baxter shares held for his account are used to buy additional shares, which are then added to his reported total of 37,076 common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/07/2026 - 04:22 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wilkes David S.

(Last) (First) (Middle)

ONE BAXTER PARKWAY

(Street)

DEERFIELD ILLINOIS 60015

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BAXTER INTERNATIONAL INC [ BAX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $1 par value	05/05/2026		A		12,836(1)	A	$0	37,076(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

2. Total includes the automatic reinvestment of dividends.

Remarks:

	/s/ Kimberly Olson, as attorney in-fact for David S. Wilkes	05/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)